Navigation Links
Finance Committee Begins Markup - Lab Fee Converted to Medicare Cut
Date:9/23/2009

WASHINGTON, Sept. 23 /PRNewswire-USNewswire/ -- Yesterday the Senate Finance Committee started marking up the America's Healthy Future Act of 2009. The revised version of the bill circulated to the Committee deletes a special provider fee on laboratories and replaces it with an additional $5 billion cut in Medicare Part B payments to clinical laboratories.

The new version of the legislation does not specify how this latest reduction will be allocated. Mark Birenbaum, PhD, the Executive Director of the National Independent Laboratory Association (NILA) and the American Association of Bioanalysts (AAB), says that "If this additional cut is not allocated properly, the reduction will put many community laboratories including those serving nursing home patients, out of business, and give large corporate laboratories that have a small percentage of Medicare Part B work a huge competitive advantage. These large corporate laboratories are the same laboratories that stand to gain from increased enrollment due to health care reform."

Dr. Birenbaum says that the Finance Committee has made a commitment to work with the National Independent Laboratory Association (NILA), and AAB, and others in the laboratory community over the next several weeks to develop an appropriate way to allocate this additional cut to adjust the impact to reflect the amount of Medicare work performed. "The structure of this provision is critical to the future of the community laboratory. It is simply not fair to have the laboratories most involved in Medicare sustain another large cut. They will not survive if some adjustment is not made," says Dr. Birenbaum.

    CONTACT: Stephanie Nagy
    202-207-3637 snagy@prismpublicaffairs.com


'/>"/>
SOURCE National Independent Laboratory Association (NILA)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
2. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
3. ISTO Technologies to Present at OneMedPlace Finance Forum
4. CryoLife to Present at OneMedPlace Finance Forum
5. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
6. DRI Capital Launches Structured Finance Fund
7. Wyeth Announces Executive Change in Finance Organization
8. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
9. Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
10. Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
11. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2020)... Ariz. (PRWEB) , ... August 13, 2020 , ... ... on its annual Inc. 5000 list, the most prestigious ranking of the nation’s ... companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... chain validation engineering firm, is making available for free its new white ... incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). In ...
(Date:8/7/2020)... WOODLANDS, Texas (PRWEB) , ... August 06, 2020 ... ... therapy and DNA vaccine industries, announces it has closed on the purchase of ... Technology Park in Conroe, TX and includes over 21 acres in the initial ...
(Date:8/3/2020)... Ky. (PRWEB) , ... August 03, 2020 , ... Introducing ... products for transformative growth, , Known as MediVet Biologics since ... brand. , The new Ardent Animal Health will build on its base ...
Breaking Biology Technology:
(Date:8/26/2020)... ... August 25, 2020 , ... ... developing novel pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical ... pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic solution in patients ...
(Date:8/21/2020)... ... August 19, 2020 , ... “How ... LLC, businesses dedicated to Salivary Bioscience for more than twenty years. Together with ... by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ," ...
(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, ... to announce that Eric Chen and Jessica Wong have joined the company’s leadership ... Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, ...
Breaking Biology News(10 mins):